New insights into disease‐modifying factors and clinical translation for central nervous system diseases

Neuroprotection · Published 2026-03-01 · DOI 10.1002/nep3.70034

Authors being retrieved — see the publisher record. https://doi.org/10.1002/nep3.70034

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Oral microbiota and central nervous system diseases: A review · Neuroprotection · 2025 · Same journal
Spinal cord transection repair occurs when Nestin+ cells differentiate into neurons within a taxol‐collagen‐enhanced microenvironment in mice · Neuroprotection · 2025 · Same journal
Effects of senescence on astrocyte to brain endothelial cell signaling · Neuroprotection · 2025 · Same journal
Post‐Omicron cognitive decline is largely reversible: Two‐year multicenter cohort study of domain‐specific outcomes in hospitalized patients · Neuroprotection · 2026 · Same journal
Exercise, exerkines, and muscle–brain crosstalk in Parkinson's disease · Neuroprotection · 2026 · Same journal
Decoding the role of large heat shock proteins in the progression of neuroinflammation‐mediated neurodegenerative disorders · Neuroprotection · 2025 · Same journal
Post‐recanalization administration of rapamycin improves functional outcome and reduces infarct size in a rat model of ischemic stroke · Neuroprotection · 2025 · Same journal
Re‐conceptualizing Parkinson's disease as a lifelong neurobiological trajectory: A framework for prevention · Neuroprotection · 2026 · Same journal
Global trends in epilepsy and the Chinese experience: Epidemiological transitions, underlying mechanisms, and integrated strategies (1990–2021) · Neuroprotection · 2026 · Same journal
Heparan sulfate and glycomimetics: Advances in synthesis and biological applications for post‐stroke neurorepair · Neuroprotection · 2026 · Same journal